Ensuring Medication for Opioid Use Disorder (MOUD) Treatment through the Care Continuum Webinar Series
More than one million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.1
However, fewer than one in five Medicare beneficiaries with an OUD diagnosis received medication to treat this condition. Also, the number of patients who stay in treatment after hospital discharge decreases drastically during the transition of care.2
This webinar series is a collaboration of all the Quality Innovation Network-Quality Improvement Organizations (QIN-QIOs) and will provide strategies, interventions and targeted solutions to ensure access to MOUD treatment and facilitate the continuity of care through the continuum.
Please join us to hear from national experts during this monthly webinar series, September 2023 through June 2024.
Sessions will take place on Fridays at 12 PM ET | 11 AM CT | 10 AM MT | 9 AM PT.
Register for this no-cost series: https://bit.ly/MOUDthroughCareContinuumSeries
Sessions 5 (Part 1: Presentation) and 6 (Part 2: Panel Discussion) – February 9, 2024 and March 8, 2024: Management of Patients on MOUD During the Nursing Home Stay Admissions assessment and treatment, addressing stigma and naloxone training